Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

GRAFT PRESERVATION SOLUTION IMPROVES ENDOTHELIAL FUNCTION AND MAINTAINS ENDOTHELIAL STRUCTURE OF SAPHENOUS VEIN GRAFTS IN PATIENTS UNDERGOING ISOLATED CABG

EF 2019-20

Résumé
"Saphenous vein grafts (SVG) remain the most often used conduits in coronary artery bypass grafting (CABG). Injury to SVG during harvesting and storage promotes thrombogenesis and neointimal hyperplasia that can progress to atherosclerosis characterized by SVG stenosis and occlusion. The long-term patency of the SVG is limited with an occlusion rate of 15% to 26% in the first year following surgery. DuraGraft® is a one-time intraoperative graft storage solution developed to protect endothelial function. The hypothesis is that DuraGraft® improves endothelial function and structural integrity because it provides a physiological pH balanced environment to the graft during storage time until anastomosis. It also contains agents that stimulate nitric oxide (NO) production and antioxidants to protect endothelial cells by decreasing reactive oxygen species (ROS) adverse effects. This study aims to investigate functional integrity of SVGs endothelium following storage in DuraGraft® vs heparinized saline by measuring SVG rings vascular reactivity when exposed to various agonists in organ chambers. The secondary objective is to identify the mechanisms responsible for endothelial preservation in DuraGraft® by measuring NO, eNOS activity, cGMP, and ROS levels in both solutions. The third objective is to investigate SVGs structural integrity via histological masson trichrome staining, cell viability assay, and immunohistochemical analysis. The current study about this innovative preservation solution is a great contribution to the improvement of clinical outcomes and intraoperative care of CABG patients. The ultimate goal is to offer patients better survival chances and life quality while lightening the burden of reoperation on the health system."
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
428993
Name
Moukhariq Fatima Zohra
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
GRAFT PRESERVATION SOLUTION IMPROVES ENDOTHELIAL FUNCTION AND MAINTAINS ENDOTHELIAL STRUCTURE OF SAPHENOUS VEIN GRAFTS IN PATIENTS UNDERGOING ISOLATED CABG
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Coronary Artery Bypass Graft Surgery; Endothelial Cells; Endothelial Dysfunction; Heparinized Saline; Human Saphenous Vein Graft; Nitric Oxide; Organ Chambers; Preservation Solutions; Reactive Oxygen Species; Vascular Reactivity
Abstract
"Saphenous vein grafts (SVG) remain the most often used conduits in coronary artery bypass grafting (CABG). Injury to SVG during harvesting and storage promotes thrombogenesis and neointimal hyperplasia that can progress to atherosclerosis characterized by SVG stenosis and occlusion. The long-term patency of the SVG is limited with an occlusion rate of 15% to 26% in the first year following surgery. DuraGraft® is a one-time intraoperative graft storage solution developed to protect endothelial function. The hypothesis is that DuraGraft® improves endothelial function and structural integrity because it provides a physiological pH balanced environment to the graft during storage time until anastomosis. It also contains agents that stimulate nitric oxide (NO) production and antioxidants to protect endothelial cells by decreasing reactive oxygen species (ROS) adverse effects. This study aims to investigate functional integrity of SVGs endothelium following storage in DuraGraft® vs heparinized saline by measuring SVG rings vascular reactivity when exposed to various agonists in organ chambers. The secondary objective is to identify the mechanisms responsible for endothelial preservation in DuraGraft® by measuring NO, eNOS activity, cGMP, and ROS levels in both solutions. The third objective is to investigate SVGs structural integrity via histological masson trichrome staining, cell viability assay, and immunohistochemical analysis. The current study about this innovative preservation solution is a great contribution to the improvement of clinical outcomes and intraoperative care of CABG patients. The ultimate goal is to offer patients better survival chances and life quality while lightening the burden of reoperation on the health system."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Moukhariq, Fatima Zohra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~